Author:
Juhlin Kristina,Karimi Ghazaleh,Andér Maria,Camilli Sara,Dheda Mukesh,Har Tan Siew,Isahak Rokiah,Lee Su-Jung,Vaughan Sarah,Caduff Pia,Norén G. Niklas
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology,Toxicology
Reference11 articles.
1. Blossom DB, Kallen AJ, Patel PR, et al. Outbreak of adverse reactions associated with contaminated heparin. N Engl J Med. 2008;359(25):2674–84.
2. Kishimoto TK, Viswanathan K, Ganguly T, et al. Contaminated heparin associated with adverse clinical events and activation of the contact system. N Engl J Med. 2008;358(23):2457–67.
3. US Food and Drug Administration. Information on heparin. 2012. http://www.fda.gov/drugs/drugsafety/postmarketdrugsafetyinformationforpatientsandproviders/ucm112597.htm . Accessed 16 Sept 2014.
4. European Medicines Agency. Questions and answers on heparins. 2008. http://www.ema.europa.eu/docs/en_GB/document_library/Medicine_QA/2009/11/WC500015169.pdf . Accessed 16 Sept 2014.
5. Khodabakhshi G, Juhlin K, Norén GN. Monitoring medicines (FP7 grant no 223566): D8-substandard medicines oversee a pilot project aimed at development of tools to identify reports indicating substandard medicines. 2011. http://www.monitoringmedicines.org/graphics/27523.pdf2011 . Accessed 5 Feb 2015.
Cited by
17 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献